跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIDAZOLAM-HAMELN 5 MG/ML INJECTION - HSA Drug Approval Details
Approvals
/
HSA
/
MIDAZOLAM-HAMELN 5 MG/ML INJECTION
Approved
THERAPEUTIC
MIDAZOLAM-HAMELN 5 MG/ML INJECTION
SIEGFRIED HAMELN GMBH - GERMANYMEFAR ILAC SANAYII A.S. (TURKEY)
🇸🇬 Health Sciences Authority
Approval Date
Jun 16, 2004
Approval ID
c06714a421d920d7
Company
SIEGFRIED HAMELN GMBH - GERMANYMEFAR ILAC SANAYII A.S. (TURKEY)
Type
Therapeutic
Approval Details
Approval Id
c06714a421d920d7
Drug Name
MIDAZOLAM-HAMELN 5 MG/ML INJECTION
Product Name
MIDAZOLAM-HAMELN 5 MG/ML INJECTION
Approval Number
SIN12553P
Approval Date
2004-06-16
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
N05CD08
Atc Item Name
midazolam
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
MIDAZOLAM HYDROCHLORIDE 5.56 mg/ml EQV MIDAZOLAM
5 mg/ml
MIDAZOLAM HYDROCHLORIDE 5.56 MG/ML EQV MIDAZOLAM
5 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 16, 2004
Approval ID
c06714a421d920d7
Type
Therapeutic
Back to HSA Approvals